New research from the University of Pennsylvania Perelman School of Medicine shows that 50% of Medicaid patients infected with chronic hepatitis C were denied coverage of newer, life-saving antiviral drugs prescribed by their doctors. Explanations included that the therapies were not considered “a medical necessity,” the patients had tested positive for alcohol/drugs, and other reasons. Researchers analyzed […]

Go to Original Post